There’s a logic to the oil majors - BP, Shell, Exxon - keeping their fossil fuel businesses to finance the move into renewables There’s also logic in their splitting the businesses so tha

LIXT stock surged 76% on positive preclinical trial data Lixte achieved the first clinical compound and PP2A inhibitor for the treatment of cancerous tumors. Stock in Lixte Biotechn

Key points Nvidia enters new partnership with autonomous commercial truck compa

NET stock has lost 8% in the last two days as tech stocks start to slip With hopes for industrial recovery crushing Omicron fears, Investors are looking  towards the Dow Jones Rising interest rates shift sentiment

As Palantir moves away from government contracts, will revenue patterns change? Partnership with Hyundai Heavy Industries marks further involvement in commercial space Investors might want to start paying attention

Beyond Meat stock rallied 10.3% during premarket trading after KFC launched its plant-based Fried Chicken across the U.S. The chicken will be available as a combo meal ordered in six or 12 pieces.

GM's uninspiring fourth-quarter leads Toyota to take the US market crown As EV's dominate the production narrative; there's little room for shortcomings The news comes as Ford swoops in and doubles production capac

Mainz Biomed today acquired the exclusive rights to a portfolio of novel mRNA biomarkers. Investors cheered the announcement to help the company’s ColoAlert colorectal cancer test become the leadi

Key points: Oracle Power just released the maiden drilling results from the Nothern Zone Gold Project in Western Australia. The results were impressive, and the miner is planning to star

Exicure has been something of a disaster, stockholders have lost 90% of their money since the IPO Finding that a leading researcher was being less than ope

Wejo is a British company quoted on NASDAQ and in the connected car space Wejo came to market through the SPAC route, not an IPO, in November As a result analyst coverage on Wejo has been scant but this is improvin

Key points: Oxford Biomedica just signed a licensing agreement with Cabaletta Bio. The deal will generate revenues for the company over multiple years. Investo

Key points: Myhealthchecked just signed a distribution deal with Lloyds Pharmacy. The deal will see Lloyds Pharmacy exclusively sell its Fit to Fly rapid COVID-19 antigen tests.

Avacta had a good - 30% - boost to its share price when it announced it had received a CE Mark for its covid test The big question was whether this jump in the share price would stick or fade So far that leap seems

Key points: ValiRx just signed a service agreement with TheoremRx, the firm looking to sub-license its VAL201 drug molecule. The agreement guarantees that ValiRx will be paid for all the

Lynas Corporation has a good story behind it - the only major rare earths processor outside China Lynas’ position may or may not survive the wave of invest

AJ Bell estimates that Metro Bank is valued at only 13% of assets The major High Street banks however are priced at some 80% of assets

  Analysts point out the unique position of Riot as exposure to the cryptocurrency market A recent increase in hash rate further bolsters the company's mining operations Not e

Disney+ attendance is expected to return by Q422 Content spending is set to increase by $8B to manage expectations Wells Fargo argue Disney is well-positioned as a 'large-cap growth stock' for 2022

Fords' F-150 Lightning truck is in high demand ahead of its Spring release Plans to double production levels came ahead of GM'S electric pickup reveal Things are looking positive for Ford's EV growth in 2022